Revisiting unexploited antibiotics in search of new antibacterial drug candidates: the case of MSD-819 (6-chloro-2-quinoxalinecarboxylic acid 1,4-dioxide)-Reference-Cited by-同舟云学术

Revisiting unexploited antibiotics in search of new antibacterial drug candidates: the case of MSD-819 (6-chloro-2-quinoxalinecarboxylic acid 1,4-dioxide)

Published:2016-11-30 Issue:3 Volume:70 Page:317-319
ISSN:0021-8820
Container-title:The Journal of Antibiotics
language:en
Short-container-title:J Antibiot

Author:

Ooi Nicola,O'Neill Alex J

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmacology

Link

http://www.nature.com/articles/ja2016140.pdf

Reference18 articles.

1. O'Neill, J. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. Rev. Antimicrob. Resist. (2014).

2. Talbot, G. H. et al. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin. Infect. Dis. 42, 657–668 (2006).

3. CDC. Antibiotic resistance threats in The United States. Available at http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf (2013).

4. Silver, L. L. Challenges of antibacterial discovery. Clin. Microbiol. Rev. 24, 71–109 (2011).

5. Lewis, K. Platforms for antibiotic discovery. Nat. Rev. Drug Disc. 12, 371–387 (2013).

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quinoxaline 1,4-Dioxides: Advances in Chemistry and Chemotherapeutic Drug Development;Pharmaceuticals;2023-08-17

2. Recent Updates on the Synthesis of Bioactive Quinoxaline-Containing Sulfonamides;Applied Sciences;2021-06-19

3. The Importance of Isolated and Purified Bacillus species as a Source of a Variety of Antimicrobial Substances;Journal of Pharmaceutical Research International;2020-12-10

4. Synergistic antibacterial activity of alpha mangostin and resveratrol loaded polymer-based films against bacteria infected wound;Journal of Drug Delivery Science and Technology;2020-06

5. Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections;Advanced Science;2019-12-05